CD19 and myasthenia gravis: It was found that the proportion of CD19+IL-10+ B cells in MG patients was significantly lower than healthy children (8 ± 1.9%) (p < 0.01) and healthy adults (3 ± 1.4%) (p < 0.05; Figures 4C, D).